Business progress update | 14-Jun-2023 | 16:46 | RNS |
SkinBiotix and AxisBiotix Update | 10-May-2023 | 07:00 | RNS |
Director/PDMR Shareholding | 14-Apr-2023 | 07:00 | RNS |
Replacement Half-year Report | 28-Mar-2023 | 13:45 | RNS |
Half-year Report | 28-Mar-2023 | 07:00 | RNS |
Price Monitoring Extension | 27-Mar-2023 | 16:35 | RNS |
Director/PDMR Shareholding | 09-Mar-2023 | 17:18 | RNS |
Director/PDMR Shareholding | 09-Mar-2023 | 17:18 | RNS |
AxisBiotix-Ps™ approved for launch in Europe | 07-Mar-2023 | 07:00 | RNS |
Holding(s) in Company | 20-Feb-2023 | 11:17 | RNS |
Result of General Meeting | 31-Jan-2023 | 11:15 | RNS |
Holding(s) in Company | 30-Jan-2023 | 16:28 | RNS |
Holding(s) in Company | 30-Jan-2023 | 09:00 | RNS |
Second Price Monitoring Extn | 16-Jan-2023 | 16:40 | RNS |
Price Monitoring Extension | 16-Jan-2023 | 16:35 | RNS |
Currency | UK Pounds |
Share Price | 10.63p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 29.00 |
52 Week Low | 7.25 |
Volume | 853,286 |
Shares Issued | 226.09m |
Market Cap | £24.02m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
15:22 | 312,500 @ 10.54p |
16:18 | 4,042 @ 10.74p |
15:53 | 20,000 @ 10.69p |
15:32 | 6,000 @ 10.69p |
15:19 | 83,833 @ 10.70p |
CEO | Stuart Ashman |
CFO | Manprit Singh Randhawa |
You are here: research